| Patient | Robert Peary |
|---|---|
| Date of birth | 1856-05-06 |
| Identifiers | MRN HR-EX004-SYN-TD; SSN (made up) 000-04-7351 |
| Document date | 2026-11-01 |
| Author | Thaddeus Lindgren-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing primary care for four months of fatigue, breathlessness, pallor, a sore tongue, and numbness and unsteadiness in the feet: blood tests, neurological and foot examination, falls, mood, the first vitamin B12 injection and a hematology consultation. Concerns: Tired and breathless doing what used to be easy; Numb, unsteady feet on top of feet that lost their toes long ago; He wants to know whether this illness can be treated, and to keep walking and working. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn | 1,000 micrograms into the muscle every other day, seven doses | Intramuscular route | 1919-01-13 to 1919-01-25 | completed | S |
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a week while the nerves recover | 1,000 micrograms into the muscle once a week, self-injected after teaching | Intramuscular route | 1919-02-01 to 1919-04-26 | completed | S |
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a month for life | 1,000 micrograms into the muscle every four weeks, self-injected, for life | Intramuscular route | 1919-04-28 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet every other day on an empty stomach with a glass of orange juice | One tablet every other day, apart from tea and coffee, for three months after the ferritin is normal | Oral route | 1919-03-10 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Upper endoscopy with biopsies by the updated Sydney protocol (two from the antrum, one from the incisura, two from the body, each site in a separate jar) and targeted biopsies: pale, thin body mucosa with visible vessels and no polyp or mass; antrum normal | 1919-02-17 to 1919-02-17 | completed | S |
| Screening colonoscopy, done at the same session: complete to the cecum, good preparation, no polyps or bleeding source | 1919-02-17 to 1919-02-17 | completed | S |
| Advance care planning conversation, about 20 minutes | 1919-03-24 to 1919-03-24 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1919-03-24 | Recombinant zoster vaccine, first of two doses | completed | S |
| 1919-03-24 | Pneumococcal conjugate vaccine (PCV20), single dose | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| July 11, 1891 | Both bones of one leg broken just above the ankle in a shipboard accident; set and healed | D (CLM-0004) |
| January to March 1899 | Frostbite of both feet in the Arctic, followed by amputation of most of the toes; stumps often injured on later journeys | D (CLM-0006) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died when his son was under three; cause not recorded in the cited source | D (CLM-0001) |
| Concern | Status | Evidence |
|---|---|---|
| Tired and breathless doing what used to be easy | active | S |
| Numb, unsteady feet on top of feet that lost their toes long ago | active | S |
| He wants to know whether this illness can be treated, and to keep walking and working | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 14.8 on 1919-04-28; MCV [Entitic mean volume] in Red Blood Cells by Automated count 90 on 1919-04-28; Erythrocyte [DistWidth] in Blood by Automated count 13.8 on 1919-04-28; Leukocytes [#/volume] in Blood by Automated count 6.2 on 1919-03-10; Platelets [#/volume] in Blood by Automated count 248 on 1919-03-10; Reticulocytes/Erythrocytes in Blood by Automated count 1.6 on 1919-02-17; Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma 190 on 1919-03-10; Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 on 1919-03-10; Sodium [Moles/volume] in Serum or Plasma 139 on 1919-01-13; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1919-02-17; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 1919-01-13; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1914)/1.73 sq M 85 on 1919-01-13; Glucose [Mass/volume] in Serum or Plasma 92 on 1919-01-13; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 96 on 1919-01-13; Folate [Mass/volume] in Serum or Plasma 14.2 on 1919-01-13; Methylmalonate [Moles/volume] in Serum or Plasma 0.26 on 1919-03-10; Homocysteine [Moles/volume] in Serum or Plasma 11 on 1919-03-10; Ferritin [Mass/volume] in Serum or Plasma 64 on 1919-04-28; Iron [Mass/volume] in Serum or Plasma 52 on 1919-03-10; Iron binding capacity [Mass/volume] in Serum or Plasma 382 on 1919-03-10; Iron saturation [Mass Fraction] in Serum or Plasma 27 on 1919-04-28; Thyrotropin [Units/volume] in Serum or Plasma 2.6 on 1919-01-13; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 1919-01-13; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1919-04-28; Total score [MoCA] 28 on 1919-04-28; Total score [AUDIT-C] 2 on 1919-01-13; Intrinsic factor Ab [Units/volume] in Serum by Immunoassay 38.5 on 1919-01-21; Parietal cell Ab [Units/volume] in Serum by Immunoassay 96 on 1919-01-21; Gastrin [Mass/volume] in Serum or Plasma 820 on 1919-01-21; Thyroperoxidase Ab [Units/volume] in Serum or Plasma 6 on 1919-01-21; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1919-03-24; Cholesterol [Mass/volume] in Serum or Plasma 196 on 1919-03-24; Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 on 1919-03-24; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 118 on 1919-03-24; Triglyceride [Mass/volume] in Serum or Plasma 100 on 1919-03-24 [S]
Strengths and supports: Strengths: physical toughness, careful planning and record-keeping, a long habit of looking after his feet in hard conditions, and a household that supports him [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fatigue, breathlessness on exertion, pallor with a lemon-yellow tinge, a sore tongue, and numbness and unsteadiness in the feet over about four months, with a macrocytic anemia, low white cells and platelets, a low vitamin B12 and a high methylmalonic acid; cause under evaluation with a hematology consultation | resolved | confirmed | D51.9 | S — Synthetic presenting problem anchored to the documented pernicious anemia of his last years; superseded when the consultation confirmed pernicious anemia. |
| Pernicious anemia (autoimmune gastritis with intrinsic factor antibodies), with severe vitamin B12 deficiency; synthetic modern diagnosis linked to the documented cause of his death | active | confirmed | D51.0 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented death from pernicious anemia; the timing and course in the modern episode are synthetic. |
| Subacute combined degeneration of the spinal cord with peripheral neuropathy from vitamin B12 deficiency: loss of vibration and joint position sense in the feet, absent ankle jerks, brisk knee jerks and a positive Romberg test | active | confirmed | G32.0 | S — Synthetic neurological complication; not a claim about his real nerves. |
| Absence of the second to fifth toes of the right foot after frostbite and amputation in early middle age; healed stumps; callus under the first metatarsal head | active | confirmed | Z89.421 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| Absence of the second to fifth toes of the left foot after frostbite and amputation in early middle age; healed stumps | active | confirmed | Z89.422 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| One fall in a dark bedroom a month ago without injury; unsteady in the dark and on uneven ground; uses a stick outdoors | active | confirmed | Z91.81 | S — Synthetic fall linked to the neuropathy and the old toe amputations. |
| Autoimmune atrophic gastritis, corpus-predominant, with intestinal metaplasia and enterochromaffin-like cell hyperplasia in the body of the stomach, a spared antrum, no Helicobacter pylori, no neuroendocrine tumor and no dysplasia | active | confirmed | K29.40 | S — Synthetic endoscopy and pathology result, the cause of the pernicious anemia; not a claim about his real stomach. |
| Iron deficiency without anemia, unmasked by the recovery of red cell production and the poor iron absorption of atrophic gastritis; colonoscopy and endoscopy without a bleeding source | active | confirmed | E61.1 | S — Synthetic finding at eight weeks. |
| Blister on the end of the left forefoot over the old amputation stump, from boots not yet broken in, in a foot with reduced sensation; no infection; healed in two weeks | resolved | confirmed | S90.822A | S — Synthetic acute foot problem; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1919-01-13 | Hemoglobin [Mass/volume] in Blood | 8.2 | g/dL | 13.2-17.1 g/dL | Low | S |
| 1919-01-13 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 118 | fL | 80-100 fL | High | S |
| 1919-01-13 | Erythrocyte [DistWidth] in Blood by Automated count | 19.6 | % | 11-15% | High | S |
| 1919-01-13 | Leukocytes [#/volume] in Blood by Automated count | 3.4 | 10*3/uL | 3.8-10.8 10*3/uL | Low | S |
| 1919-01-13 | Platelets [#/volume] in Blood by Automated count | 118 | 10*3/uL | 140-400 10*3/uL | Low | S |
| 1919-01-13 | Reticulocytes/Erythrocytes in Blood by Automated count | 0.4 | % | 0.5-2.5% | Low | S |
| 1919-01-13 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 1240 | U/L | 120-250 U/L | High | S |
| 1919-01-13 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1.9 | mg/dL | 0.2-1.2 mg/dL | High | S |
| 1919-01-13 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-146 mmol/L | Normal | S |
| 1919-01-13 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1919-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 1919-01-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1914)/1.73 sq M | 85 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1919-01-13 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 65-99 mg/dL | Normal | S |
| 1919-01-13 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 96 | pg/mL | 200-1100 pg/mL | Low | S |
| 1919-01-13 | Folate [Mass/volume] in Serum or Plasma | 14.2 | ng/mL | >=5.4 ng/mL | Normal | S |
| 1919-01-13 | Methylmalonate [Moles/volume] in Serum or Plasma | 3.1 | umol/L | <=0.4 umol/L | High | S |
| 1919-01-13 | Homocysteine [Moles/volume] in Serum or Plasma | 38 | umol/L | <=15 umol/L | High | S |
| 1919-01-13 | Ferritin [Mass/volume] in Serum or Plasma | 62 | ng/mL | 30-400 ng/mL | Normal | S |
| 1919-01-13 | Iron [Mass/volume] in Serum or Plasma | 148 | ug/dL | 50-180 ug/dL | Normal | S |
| 1919-01-13 | Iron binding capacity [Mass/volume] in Serum or Plasma | 268 | ug/dL | 250-425 ug/dL | Normal | S |
| 1919-01-13 | Iron saturation [Mass Fraction] in Serum or Plasma | 55 | % | 20-50% | High | S |
| 1919-01-13 | Thyrotropin [Units/volume] in Serum or Plasma | 2.6 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1919-01-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 1919-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1919-01-13 | Total score [MoCA] | 27 | {score} | S | ||
| 1919-01-13 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 1919-01-21 | Hemoglobin [Mass/volume] in Blood | 8.9 | g/dL | 13.2-17.1 g/dL | Low | S |
| 1919-01-21 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 114 | fL | 80-100 fL | High | S |
| 1919-01-21 | Leukocytes [#/volume] in Blood by Automated count | 4.6 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 1919-01-21 | Platelets [#/volume] in Blood by Automated count | 186 | 10*3/uL | 140-400 10*3/uL | Normal | S |
| 1919-01-21 | Reticulocytes/Erythrocytes in Blood by Automated count | 7.9 | % | 0.5-2.5% | High | S |
| 1919-01-21 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1919-01-21 | Intrinsic factor Ab [Units/volume] in Serum by Immunoassay | 38.5 | [arb'U]/mL | 1.1 AU/mL or less: negative | High | S |
| 1919-01-21 | Parietal cell Ab [Units/volume] in Serum by Immunoassay | 96 | [arb'U]/mL | Below 20.1: negative | High | S |
| 1919-01-21 | Gastrin [Mass/volume] in Serum or Plasma | 820 | pg/mL | <=100 pg/mL | High | S |
| 1919-01-21 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma | 6 | [IU]/mL | <=8 [IU]/mL | Normal | S |
| 1919-02-17 | Hemoglobin [Mass/volume] in Blood | 12 | g/dL | 13.2-17.1 g/dL | Low | S |
| 1919-02-17 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 | fL | 80-100 fL | High | S |
| 1919-02-17 | Leukocytes [#/volume] in Blood by Automated count | 5.6 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 1919-02-17 | Platelets [#/volume] in Blood by Automated count | 232 | 10*3/uL | 140-400 10*3/uL | Normal | S |
| 1919-02-17 | Reticulocytes/Erythrocytes in Blood by Automated count | 1.6 | % | 0.5-2.5% | Normal | S |
| 1919-02-17 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1919-03-10 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1919-03-10 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 91 | fL | 80-100 fL | Normal | S |
| 1919-03-10 | Erythrocyte [DistWidth] in Blood by Automated count | 15.6 | % | 11-15% | High | S |
| 1919-03-10 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 1919-03-10 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 140-400 10*3/uL | Normal | S |
| 1919-03-10 | Methylmalonate [Moles/volume] in Serum or Plasma | 0.26 | umol/L | <=0.4 umol/L | Normal | S |
| 1919-03-10 | Homocysteine [Moles/volume] in Serum or Plasma | 11 | umol/L | <=15 umol/L | Normal | S |
| 1919-03-10 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 190 | U/L | 120-250 U/L | Normal | S |
| 1919-03-10 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.2-1.2 mg/dL | Normal | S |
| 1919-03-10 | Ferritin [Mass/volume] in Serum or Plasma | 24 | ng/mL | 30-400 ng/mL | Low | S |
| 1919-03-10 | Iron [Mass/volume] in Serum or Plasma | 52 | ug/dL | 50-180 ug/dL | Normal | S |
| 1919-03-10 | Iron binding capacity [Mass/volume] in Serum or Plasma | 382 | ug/dL | 250-425 ug/dL | Normal | S |
| 1919-03-10 | Iron saturation [Mass Fraction] in Serum or Plasma | 14 | % | 20-50% | Low | S |
| 1919-03-24 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1919-03-24 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | <=199 mg/dL | Normal | S |
| 1919-03-24 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 58 | mg/dL | >=40 mg/dL | Normal | S |
| 1919-03-24 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 118 | mg/dL | <=99 mg/dL | High | S |
| 1919-03-24 | Triglyceride [Mass/volume] in Serum or Plasma | 100 | mg/dL | <=149 mg/dL | Normal | S |
| 1919-04-28 | Hemoglobin [Mass/volume] in Blood | 14.8 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1919-04-28 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 90 | fL | 80-100 fL | Normal | S |
| 1919-04-28 | Erythrocyte [DistWidth] in Blood by Automated count | 13.8 | % | 11-15% | Normal | S |
| 1919-04-28 | Ferritin [Mass/volume] in Serum or Plasma | 64 | ng/mL | 30-400 ng/mL | Normal | S |
| 1919-04-28 | Iron saturation [Mass Fraction] in Serum or Plasma | 27 | % | 20-50% | Normal | S |
| 1919-04-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 1919-04-28 | Total score [MoCA] | 28 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1919-01-13 | Body height | 183 | cm | S |
| 1919-01-13 | Body weight | 72.4 | kg | S |
| 1919-01-13 | Body mass index (BMI) [Ratio] | 21.6 | kg/m2 | S |
| 1919-01-13 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1919-01-13 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1919-01-13 | Heart rate | 102 | /min | S |
| 1919-01-13 | Respiratory rate | 18 | /min | S |
| 1919-01-13 | Body temperature | 36.7 | Cel | S |
| 1919-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1919-01-21 | Body height | 183 | cm | S |
| 1919-01-21 | Body weight | 72.6 | kg | S |
| 1919-01-21 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 1919-01-21 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1919-01-21 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1919-01-21 | Heart rate | 94 | /min | S |
| 1919-01-21 | Respiratory rate | 16 | /min | S |
| 1919-01-21 | Body temperature | 36.6 | Cel | S |
| 1919-01-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1919-02-17 | Body height | 183 | cm | S |
| 1919-02-17 | Body weight | 73.4 | kg | S |
| 1919-02-17 | Body mass index (BMI) [Ratio] | 21.9 | kg/m2 | S |
| 1919-02-17 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1919-02-17 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1919-02-17 | Heart rate | 80 | /min | S |
| 1919-02-17 | Respiratory rate | 16 | /min | S |
| 1919-02-17 | Body temperature | 36.6 | Cel | S |
| 1919-02-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1919-03-10 | Body height | 183 | cm | S |
| 1919-03-10 | Body weight | 74 | kg | S |
| 1919-03-10 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 1919-03-10 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1919-03-10 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1919-03-10 | Heart rate | 74 | /min | S |
| 1919-03-10 | Respiratory rate | 14 | /min | S |
| 1919-03-10 | Body temperature | 36.6 | Cel | S |
| 1919-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1919-04-28 | Body height | 183 | cm | S |
| 1919-04-28 | Body weight | 74.6 | kg | S |
| 1919-04-28 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 1919-04-28 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1919-04-28 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1919-04-28 | Heart rate | 70 | /min | S |
| 1919-04-28 | Respiratory rate | 14 | /min | S |
| 1919-04-28 | Body temperature | 36.6 | Cel | S |
| 1919-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1919-03-24 | Body height | 183 | cm | S |
| 1919-03-24 | Body weight | 74.2 | kg | S |
| 1919-03-24 | Body mass index (BMI) [Ratio] | 22.2 | kg/m2 | S |
| 1919-03-24 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1919-03-24 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1919-03-24 | Heart rate | 72 | /min | S |
| 1919-03-24 | Respiratory rate | 14 | /min | S |
| 1919-03-24 | Body temperature | 36.6 | Cel | S |
| 1919-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1919-02-03 | Body height | 183 | cm | S |
| 1919-02-03 | Body weight | 72.8 | kg | S |
| 1919-02-03 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 1919-02-03 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1919-02-03 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1919-02-03 | Heart rate | 88 | /min | S |
| 1919-02-03 | Respiratory rate | 16 | /min | S |
| 1919-02-03 | Body temperature | 36.7 | Cel | S |
| 1919-02-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1919-01-13 | Establishing primary care for four months of fatigue, breathlessness, pallor, a sore tongue, and numbness and unsteadiness in the feet: blood tests, neurological and foot examination, falls, mood, the first vitamin B12 injection and a hematology consultation | finished | S |
| 1919-01-21 | Eight-day review with the reticulocyte response and potassium, seen the same day by hematology: the cause, the injection plan, endoscopy, autoimmune screening and the nerves | finished | S |
| 1919-02-17 | Five-week review on the day of upper endoscopy and colonoscopy: blood count, nerves, falls and feet | finished | S |
| 1919-03-10 | Eight-week review: blood count, methylmalonic acid, iron studies, the endoscopy biopsies and surveillance | finished | S |
| 1919-04-28 | Fifteen-week review: neurological recovery, iron, lifelong maintenance and the plan ahead | finished | S |
| 1919-03-24 | Periodic adult preventive visit | finished | S |
| 1919-02-03 | Same-day sick visit for a blister on the left forefoot | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Diagnosis: blood count with MCV, smear and reticulocytes; vitamin B12, methylmalonic acid, homocysteine and folate; iron studies, LDH and bilirubin; kidney function; TSH and HbA1c; all drawn before the first injection | completed | GL-BSH-B12-2014, GL-NICE-B12-2024, GL-CMID-2026 | S |
| Hematology consultation to confirm the cause and advise on treatment, endoscopy and follow-up | completed | GL-BSH-B12-2014, GL-AGA-AG-2021 | S |
| Treatment started at intake without waiting for the cause, because of neurological signs: cyanocobalamin 1,000 micrograms into the muscle every other day for seven doses; no folic acid alone; no transfusion while he is stable at rest | completed | GL-BSH-B12-2014, GL-NICE-B12-2024 | S |
| Maintenance: weekly injections, taught for self-injection, until neurological improvement levels off, then monthly injections for life; high-dose oral cyanocobalamin (at least 1 mg a day) offered as an alternative; vitamin B12 levels not rechecked routinely once treated | completed | GL-BSH-B12-2014, GL-NICE-B12-2024, GL-CMID-2026 | S |
| Response and safety checks: reticulocytes and potassium in the first week, blood count at about five and eight weeks, methylmalonic acid and homocysteine and iron studies at eight weeks, and symptoms at every visit | completed | GL-CMID-2026, GL-BSH-B12-2014 | S |
| Stomach: upper endoscopy with biopsies by the updated Sydney protocol to confirm autoimmune gastritis and look for neuroendocrine tumors and dysplasia, with a screening colonoscopy at the same session; surveillance interval set from the findings by shared decision; thyroid antibodies checked | completed | GL-AGA-AG-2021, GL-NICE-B12-2024, GL-USPSTF-CRC-2021 | S |
| Nerves and falls: neurological examination (vibration, joint position, reflexes, Romberg, gait, cognition) at each visit; physical therapy for balance and gait; night lights and a clear path at home; a stick outdoors and care on ice | completed | GL-CMID-2026, GL-USPSTF-FALLS-2024 | S |
| Feet: daily skin checks with a mirror, extra-depth shoes with toe fillers and a forefoot rocker sole, no new boots without a fitting, nail and callus care by podiatry every three months, and same-day care for any blister, redness or wound | completed | GL-IWGDF-2023 | S |
| Mood and cognition: PHQ-9 and MoCA at intake and after treatment, since vitamin B12 deficiency can affect both | completed | GL-CMID-2026, GL-USPSTF-DEP-2023, GL-NICE-B12-2024 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Find the cause of the anemia and the numb feet | 1919-01-21 | completed | Pernicious anemia confirmed: intrinsic factor and parietal cell antibodies positive, gastrin high | S |
| Normal hemoglobin and MCV within eight weeks | 1919-03-10 | completed | Hemoglobin 8.2 to 14.1 g/dL and MCV 118 to 91 fL at eight weeks | S |
| Recover feeling and balance in the feet and walk without falls | 1919-10-27 | active | At fifteen weeks: vibration sense back at the ankles, Romberg negative, Timed Up and Go 10 seconds, no falls; numbness at the ends of the feet persists | S |
| No foot wound that goes unnoticed | 1919-10-27 | active | Daily foot checks; one blister found early and healed in two weeks; podiatry every three months | S |
| Gastric surveillance planned with him | 1919-03-10 | completed | Endoscopy without neuroendocrine tumor or dysplasia; repeat in three years by shared decision | S |